Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO 2025-11-03 20:00
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine' 2025-11-03 13:26
Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer 2025-11-03 12:12
Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial. 2025-10-31 21:00
Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer 2025-10-31 20:00
U.S. FDA grants interchangeability designation to Celltrion's denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) 2025-10-30 15:28
IASO Bio Partners with Korea's GC Cell to Bring CAR-T Therapy to Korea 2025-10-29 17:01
What Hebei Can Offer丨Biomedicine and Beyond 2025-10-29 15:23
Tsingke Biotech Showcased AI-Powered Biomanufacturing Solutions at 2025 Festival of Biologics 2025-10-28 22:47
Harbour BioMed Launches First Fully Human Generative AI HCAb Model to Accelerate Next-Generation Biologics Discovery 2025-10-28 22:07
TCI Biotech to Showcase Leadership as the "Liquid Expert" at SupplySide Global 2025, Featuring Clinically-Proven Innovations for Weight Management and Metabolic Health 2025-10-28 22:00
Noul Supplies AI Diagnostic Platform miLab™ to Charité, Europe's Leading University Hospital 2025-10-28 21:00
Myrio Therapeutics Announces Collaboration with Leading Research Institutions to Advance Solid Tumor T cell Immunotherapeutics 2025-10-28 19:35
WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health 2025-10-28 17:00
Samsung Biologics reports third quarter 2025 financial results 2025-10-28 14:50
Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner 2025-10-27 19:15
MINISH Technology Has Successfully Concluded Its First U.S. MINISH Veneers Course, Certifying 22 Dentists 2025-10-27 14:58
Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement 2025-10-25 15:00
Global Launch Event for iza-bren Phase III Nasopharyngeal Carcinoma Research Results Successfully Held, Streamed on ESMO Official Website 2025-10-24 16:40
HanchorBio Presents Phase 1 HCB101 Clinical Results at FACO 2025 Demonstrating Safety and Early Antitumor Activity 2025-10-24 07:30
1 2 3 4 5 6 260